Literature DB >> 15778504

Novel heparan sulfate structures revealed by monoclonal antibodies.

Jacob van den Born1, Katriina Salmivirta, Tiina Henttinen, Nina Ostman, Takeshi Ishimaru, Shuichi Miyaura, Keiichi Yoshida, Markku Salmivirta.   

Abstract

The sulfated glycosaminoglycan heparan sulfate (HS) is found ubiquitously on cell surfaces, in the extracellular matrix, and intracellularly as HS proteoglycans. Because of the structural heterogeneity of HS, tissue-derived HS preparations represent a mixture of HS chains originating from different cell types and tissue loci. Monoclonal anti-HS antibodies have been employed to detect the localization of specific HS epitopes in tissues, but limited information has been available on the saccharide structures recognized by the antibodies. We have studied the saccharide epitope structures of four anti-HS antibodies, HepSS1, JM13, JM403, and 10E4, which all recognize distinct HS species as demonstrated by different patterns of immunoreactivity upon staining of embryonic rat and adult human tissues. The epitopes recognized by JM13 and HepSS1 were found almost exclusively in basement membrane HS, whereas JM403 and 10E4 reacted also with cell-associated HS species. The binding of HepSS1, JM403, and 10E4 to HS was dependent on the GlcN N-substitution of the polysaccharide rather than O-sulfation. HepSS1 thus interacted with N-sulfated HS domains, JM403 binding was critically dependent on N-unsubstituted GlcN residues, and 10E4 bound to "mixed" HS domains containing both N-acetylated and N-sulfated disaccharide units. By contrast, JM13 binding seemed to require the presence of 2-O-sulfated glucuronic acid residues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778504     DOI: 10.1074/jbc.M502065200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

2.  Molecular changes in the vasculature of injured tissues.

Authors:  Tero A H Järvinen; Erkki Ruoslahti
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

3.  Cytoplasmic expression of the JM403 antigen GlcA-GlcNH3+ on heparan sulfate glycosaminoglycan in mammary carcinomas--a novel proliferative biomarker for breast cancers with high malignancy.

Authors:  Masahiro Fujii; Akiko Yusa; Yukihiro Yokoyama; Toshio Kokuryo; Nobuyuki Tsunoda; Koji Oda; Masato Nagino; Tsuyoshi Ishimaru; Yoshie Shimoyama; Hirotoshi Utsunomiya; Hiroji Iwata; Yoshiko Itoh; Johbu Itoh; Reiji Kannagi; Mamoru Kyogashima
Journal:  Glycoconj J       Date:  2010-11-03       Impact factor: 2.916

4.  Heparan sulfate expression in the neural crest is essential for mouse cardiogenesis.

Authors:  Yi Pan; Christian Carbe; Sabine Kupich; Ute Pickhinke; Stefanie Ohlig; Maike Frye; Ruth Seelige; Srinivas R Pallerla; Anne M Moon; Roger Lawrence; Jeffrey D Esko; Xin Zhang; Kay Grobe
Journal:  Matrix Biol       Date:  2013-11-05       Impact factor: 11.583

5.  Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell line.

Authors:  Jennifer Y C Cheng; John Whitelock; Laura Poole-Warren
Journal:  Histochem Cell Biol       Date:  2012-08-08       Impact factor: 4.304

6.  Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.

Authors:  Satomi Nadanaka; Eko Purunomo; Naoko Takeda; Jun-ichi Tamura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

7.  Antiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site.

Authors:  Miaomiao Li; Ding Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-07       Impact factor: 11.205

8.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.

Authors:  Martin D Rees; John M Whitelock; Ernst Malle; Christine Y Chuang; Renato V Iozzo; Anastasia Nilasaroya; Michael J Davies
Journal:  Matrix Biol       Date:  2009-09-27       Impact factor: 11.583

10.  Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains.

Authors:  Eleanor C Kennett; Martin D Rees; Ernst Malle; Astrid Hammer; John M Whitelock; Michael J Davies
Journal:  Free Radic Biol Med       Date:  2010-04-21       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.